Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2002 Aug;110(Suppl 4):655–661. doi: 10.1289/ehp.02110s4655

The vomeronasal organ and chemical sensitivity: a hypothesis.

Glenn J Greene 1, Howard M Kipen 1
PMCID: PMC1241221  PMID: 12194902

Abstract

Environmental exposures to very low levels of airborne chemicals are associated with adverse symptoms, often affecting multiple organ systems, in the phenomenon of chemical sensitivity (CS). Recent surveys suggest a significant prevalence of chemically sensitive subjects in the United States, but the mechanism linking exposure to symptoms remains unclear, despite the advancement of a variety of theoretical models. In many of these models, exposure of the nasal respiratory system to an airborne agent is the first step in the pathway leading to symptoms. In this article, we advance the hypothesis that interactions between environmental chemicals and the vomeronasal organ (VNO) may play a role in the etiology of CS. The VNO, a bilateral, tubular organ located in the nose, serves in animals as part of a sensitive chemosensory system; however, evidence suggesting that the VNO retains a functional role in the adult human is controversial. Reported characteristics of the human VNO relevant to CS, including location, prevalence, selective sensitivity to airborne chemical exposure, and capacity to produce systemic effects, are discussed within the context of this ongoing debate. Beyond relevance to CS, the demonstration of an active, adult VNO could have significant impact on environmental toxicology.

Full Text

The Full Text of this article is available as a PDF (527.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abolmaali N. D., Kühnau D., Knecht M., Köhler K., Hüttenbrink K. B., Hummel T. Imaging of the human vomeronasal duct. Chem Senses. 2001 Jan;26(1):35–39. doi: 10.1093/chemse/26.1.35. [DOI] [PubMed] [Google Scholar]
  2. Amundsen M. A., Hanson N. P., Bruce B. K., Lantz T. D., Schwartz M. S., Lukach B. M. Odor aversion of multiple chemical sensitivities: recommendation for a name change and description of successful behavioral medicine treatment. Regul Toxicol Pharmacol. 1996 Aug;24(1 Pt 2):S116–S118. doi: 10.1006/rtph.1996.0086. [DOI] [PubMed] [Google Scholar]
  3. Ashford N. A. Low-level chemical sensitivity: implications for research and social policy. Toxicol Ind Health. 1999 Apr-Jun;15(3-4):421–427. doi: 10.1177/074823379901500317. [DOI] [PubMed] [Google Scholar]
  4. Baldwin C. M., Bell I. R., O'Rourke M. K. Odor sensitivity and respiratory complaint profiles in a community-based sample with asthma, hay fever, and chemical odor intolerance. Toxicol Ind Health. 1999 Apr-Jun;15(3-4):403–409. doi: 10.1177/074823379901500314. [DOI] [PubMed] [Google Scholar]
  5. Barber P. C., Raisman G. An autoradiographic investigation of the projection of the vomeronasal organ to the accessory olfactory bulb in the mouse. Brain Res. 1974 Nov 29;81(1):21–30. doi: 10.1016/0006-8993(74)90476-4. [DOI] [PubMed] [Google Scholar]
  6. Bascom R. Multiple chemical sensitivity: a respiratory disorder? Toxicol Ind Health. 1992 Jul-Aug;8(4):221–228. [PubMed] [Google Scholar]
  7. Bell I. R., Miller C. S., Schwartz G. E. An olfactory-limbic model of multiple chemical sensitivity syndrome: possible relationships to kindling and affective spectrum disorders. Biol Psychiatry. 1992 Aug 1;32(3):218–242. doi: 10.1016/0006-3223(92)90105-9. [DOI] [PubMed] [Google Scholar]
  8. Bell I. R., Schwartz G. E., Peterson J. M., Amend D. Self-reported illness from chemical odors in young adults without clinical syndromes or occupational exposures. Arch Environ Health. 1993 Jan-Feb;48(1):6–13. doi: 10.1080/00039896.1993.9938387. [DOI] [PubMed] [Google Scholar]
  9. Berliner D. L., Monti-Bloch L., Jennings-White C., Diaz-Sanchez V. The functionality of the human vomeronasal organ (VNO): evidence for steroid receptors. J Steroid Biochem Mol Biol. 1996 Jun;58(3):259–265. doi: 10.1016/0960-0760(96)00062-3. [DOI] [PubMed] [Google Scholar]
  10. Berliner D. L. Steroidal substances active in the human vomeronasal organ affect hypothalamic function. J Steroid Biochem Mol Biol. 1996 Apr;58(1):1–2. doi: 10.1016/0960-0760(96)00011-8. [DOI] [PubMed] [Google Scholar]
  11. Black D. W., Rathe A., Goldstein R. B. Environmental illness. A controlled study of 26 subjects with '20th century disease'. JAMA. 1990 Dec 26;264(24):3166–3170. doi: 10.1001/jama.264.24.3166. [DOI] [PubMed] [Google Scholar]
  12. Bolla-Wilson K., Wilson R. J., Bleecker M. L. Conditioning of physical symptoms after neurotoxic exposure. J Occup Med. 1988 Sep;30(9):684–686. [PubMed] [Google Scholar]
  13. Bowler R. M., Huel G., Mergler D., Cone J. E., Rauch S. S., Hartney C. Symptom base rates after chemical exposure for white, Hispanic and African-Americans. Neurotoxicology. 1996 Fall-Winter;17(3-4):793–802. [PubMed] [Google Scholar]
  14. Brown A. E. Developing a pesticide policy for individuals with multiple chemical sensitivity: considerations for institutions. Toxicol Ind Health. 1999 Apr-Jun;15(3-4):432–437. doi: 10.1177/074823379901500319. [DOI] [PubMed] [Google Scholar]
  15. Cone J. E., Sult T. A. Acquired intolerance to solvents following pesticide/solvent exposure in a building: a new group of workers at risk for multiple chemical sensitivities? Toxicol Ind Health. 1992 Jul-Aug;8(4):29–39. [PubMed] [Google Scholar]
  16. Cullen M. R. The worker with multiple chemical sensitivities: an overview. Occup Med. 1987 Oct-Dec;2(4):655–661. [PubMed] [Google Scholar]
  17. Custer W. V., Kertscher E. T. The development of judicial policy on the phenomenon of multiple chemical sensitivity in the post-Daubert era. Toxicol Ind Health. 1999 Apr-Jun;15(3-4):428–431. doi: 10.1177/074823379901500318. [DOI] [PubMed] [Google Scholar]
  18. Cutler W. B., Preti G., Krieger A., Huggins G. R., Garcia C. R., Lawley H. J. Human axillary secretions influence women's menstrual cycles: the role of donor extract from men. Horm Behav. 1986 Dec;20(4):463–473. doi: 10.1016/0018-506x(86)90008-5. [DOI] [PubMed] [Google Scholar]
  19. Dyer R. S., Sexton K. What can research contribute to regulatory decisions about the health risks of multiple chemical sensitivity? Regul Toxicol Pharmacol. 1996 Aug;24(1 Pt 2):S139–S151. doi: 10.1006/rtph.1996.0090. [DOI] [PubMed] [Google Scholar]
  20. Fiedler N., Kipen H. M., DeLuca J., Kelly-McNeil K., Natelson B. A controlled comparison of multiple chemical sensitivities and chronic fatigue syndrome. Psychosom Med. 1996 Jan-Feb;58(1):38–49. doi: 10.1097/00006842-199601000-00007. [DOI] [PubMed] [Google Scholar]
  21. Fiedler N., Kipen H. Chemical sensitivity: the scientific literature. Environ Health Perspect. 1997 Mar;105 (Suppl 2):409–415. doi: 10.1289/ehp.97105s2409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Fiedler N., Maccia C., Kipen H. Evaluation of chemically sensitive patients. J Occup Med. 1992 May;34(5):529–538. [PubMed] [Google Scholar]
  23. Garcia-Velasco J., Mondragon M. The incidence of the vomeronasal organ in 1000 human subjects and its possible clinical significance. J Steroid Biochem Mol Biol. 1991 Oct;39(4B):561–563. doi: 10.1016/0960-0760(91)90253-2. [DOI] [PubMed] [Google Scholar]
  24. Gots R. E. Medical hypothesis and medical practice: autointoxication and multiple chemical sensitivities. Regul Toxicol Pharmacol. 1993 Aug;18(1):2–12. doi: 10.1006/rtph.1993.1039. [DOI] [PubMed] [Google Scholar]
  25. Graveling R. A., Pilkington A., George J. P., Butler M. P., Tannahill S. N. A review of multiple chemical sensitivity. Occup Environ Med. 1999 Feb;56(2):73–85. doi: 10.1136/oem.56.2.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Grosser B. I., Monti-Bloch L., Jennings-White C., Berliner D. L. Behavioral and electrophysiological effects of androstadienone, a human pheromone. Psychoneuroendocrinology. 2000 Apr;25(3):289–299. doi: 10.1016/s0306-4530(99)00056-6. [DOI] [PubMed] [Google Scholar]
  27. Jacob S., Zelano B., Gungor A., Abbott D., Naclerio R., McClintock M. K. Location and gross morphology of the nasopalatine duct in human adults. Arch Otolaryngol Head Neck Surg. 2000 Jun;126(6):741–748. doi: 10.1001/archotol.126.6.741. [DOI] [PubMed] [Google Scholar]
  28. Johnson A., Josephson R., Hawke M. Clinical and histological evidence for the presence of the vomeronasal (Jacobson's) organ in adult humans. J Otolaryngol. 1985 Apr;14(2):71–79. [PubMed] [Google Scholar]
  29. KARLSON P., LUSCHER M. Pheromones': a new term for a class of biologically active substances. Nature. 1959 Jan 3;183(4653):55–56. doi: 10.1038/183055a0. [DOI] [PubMed] [Google Scholar]
  30. Kaires P. Symptoms in Persian Gulf War veterans. J Occup Environ Med. 1999 Nov;41(11):939–939. doi: 10.1097/00043764-199911000-00002. [DOI] [PubMed] [Google Scholar]
  31. Keverne E. B. The vomeronasal organ. Science. 1999 Oct 22;286(5440):716–720. doi: 10.1126/science.286.5440.716. [DOI] [PubMed] [Google Scholar]
  32. Kipen H. M., Fiedler N. Invited commentary: sensitivities to chemicals--context and implications. Am J Epidemiol. 1999 Jul 1;150(1):13–17. doi: 10.1093/oxfordjournals.aje.a009911. [DOI] [PubMed] [Google Scholar]
  33. Kipen H. M., Hallman W., Kang H., Fiedler N., Natelson B. H. Prevalence of chronic fatigue and chemical sensitivities in Gulf Registry Veterans. Arch Environ Health. 1999 Sep-Oct;54(5):313–318. doi: 10.1080/00039899909602493. [DOI] [PubMed] [Google Scholar]
  34. Kipen H. M., Hallman W., Kelly-McNeil K., Fiedler N. Measuring chemical sensitivity prevalence: a questionnaire for population studies. Am J Public Health. 1995 Apr;85(4):574–577. doi: 10.2105/ajph.85.4.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Kipen H., Fiedler N. Experimental approaches to chemical sensitivity: introduction and overview. Environ Health Perspect. 1997 Mar;105 (Suppl 2):405–407. doi: 10.1289/ehp.97105s2405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Kreutzer R., Neutra R. R., Lashuay N. Prevalence of people reporting sensitivities to chemicals in a population-based survey. Am J Epidemiol. 1999 Jul 1;150(1):1–12. doi: 10.1093/oxfordjournals.aje.a009908. [DOI] [PubMed] [Google Scholar]
  37. Lax M. B. Multiple chemical sensitivities: the social construction of an illness. Int J Health Serv. 1998;28(4):725–745. doi: 10.2190/757T-JGBV-M6G2-Y3U2. [DOI] [PubMed] [Google Scholar]
  38. MacPhail R. C. Evolving concepts of chemical sensitivity. Environ Health Perspect. 1997 Mar;105 (Suppl 2):455–456. doi: 10.1289/ehp.97105s2455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Matsunami H., Buck L. B. A multigene family encoding a diverse array of putative pheromone receptors in mammals. Cell. 1997 Aug 22;90(4):775–784. doi: 10.1016/s0092-8674(00)80537-1. [DOI] [PubMed] [Google Scholar]
  40. McClintock M. K. Menstrual synchorony and suppression. Nature. 1971 Jan 22;229(5282):244–245. doi: 10.1038/229244a0. [DOI] [PubMed] [Google Scholar]
  41. Meggs W. J., Cleveland C. H., Jr Rhinolaryngoscopic examination of patients with the multiple chemical sensitivity syndrome. Arch Environ Health. 1993 Jan-Feb;48(1):14–18. doi: 10.1080/00039896.1993.9938388. [DOI] [PubMed] [Google Scholar]
  42. Meggs W. J., Dunn K. A., Bloch R. M., Goodman P. E., Davidoff A. L. Prevalence and nature of allergy and chemical sensitivity in a general population. Arch Environ Health. 1996 Jul-Aug;51(4):275–282. doi: 10.1080/00039896.1996.9936026. [DOI] [PubMed] [Google Scholar]
  43. Meggs W. J. Mechanisms of allergy and chemical sensitivity. Toxicol Ind Health. 1999 Apr-Jun;15(3-4):331–338. doi: 10.1177/074823379901500307. [DOI] [PubMed] [Google Scholar]
  44. Miller C. S. Are we on the threshold of a new theory of disease? Toxicant-induced loss of tolerance and its relationship to addiction and abdiction. Toxicol Ind Health. 1999 Apr-Jun;15(3-4):284–294. doi: 10.1177/074823379901500302. [DOI] [PubMed] [Google Scholar]
  45. Miller C. S., Prihoda T. J. A controlled comparison of symptoms and chemical intolerances reported by Gulf War veterans, implant recipients and persons with multiple chemical sensitivity. Toxicol Ind Health. 1999 Apr-Jun;15(3-4):386–397. doi: 10.1177/074823379901500312. [DOI] [PubMed] [Google Scholar]
  46. Miller C. S. Toxicant-induced loss of tolerance--an emerging theory of disease? Environ Health Perspect. 1997 Mar;105 (Suppl 2):445–453. doi: 10.1289/ehp.97105s2445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Monti-Bloch L., Diaz-Sanchez V., Jennings-White C., Berliner D. L. Modulation of serum testosterone and autonomic function through stimulation of the male human vomeronasal organ (VNO) with pregna-4,20-diene-3,6-dione. J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):237–242. doi: 10.1016/s0960-0760(98)00025-9. [DOI] [PubMed] [Google Scholar]
  48. Monti-Bloch L., Grosser B. I. Effect of putative pheromones on the electrical activity of the human vomeronasal organ and olfactory epithelium. J Steroid Biochem Mol Biol. 1991 Oct;39(4B):573–582. doi: 10.1016/0960-0760(91)90255-4. [DOI] [PubMed] [Google Scholar]
  49. Monti-Bloch L., Jennings-White C., Berliner D. L. The human vomeronasal system. A review. Ann N Y Acad Sci. 1998 Nov 30;855:373–389. doi: 10.1111/j.1749-6632.1998.tb10595.x. [DOI] [PubMed] [Google Scholar]
  50. Monti-Bloch L., Jennings-White C., Dolberg D. S., Berliner D. L. The human vomeronasal system. Psychoneuroendocrinology. 1994;19(5-7):673–686. doi: 10.1016/0306-4530(94)90049-3. [DOI] [PubMed] [Google Scholar]
  51. Monti-Bloch L., Jennings-White C., Dolberg D. S., Berliner D. L. The human vomeronasal system. Psychoneuroendocrinology. 1994;19(5-7):673–686. doi: 10.1016/0306-4530(94)90049-3. [DOI] [PubMed] [Google Scholar]
  52. Moran D. T., Jafek B. W., Rowley J. C., 3rd The vomeronasal (Jacobson's) organ in man: ultrastructure and frequency of occurrence. J Steroid Biochem Mol Biol. 1991 Oct;39(4B):545–552. doi: 10.1016/0960-0760(91)90251-y. [DOI] [PubMed] [Google Scholar]
  53. Multiple chemical sensitivity: a 1999 consensus. Arch Environ Health. 1999 May-Jun;54(3):147–149. doi: 10.1080/00039899909602251. [DOI] [PubMed] [Google Scholar]
  54. Nethercott J. R., Davidoff L. L., Curbow B., Abbey H. Multiple chemical sensitivities syndrome: toward a working case definition. Arch Environ Health. 1993 Jan-Feb;48(1):19–26. doi: 10.1080/00039896.1993.9938389. [DOI] [PubMed] [Google Scholar]
  55. Osterhammel P., Terkildsen K., Zilstorff K. Electro-olfactograms in man. J Laryngol Otol. 1969 Jul;83(7):731–733. doi: 10.1017/s0022215100070894. [DOI] [PubMed] [Google Scholar]
  56. Preti G., Cutler W. B., Garcia C. R., Huggins G. R., Lawley H. J. Human axillary secretions influence women's menstrual cycles: the role of donor extract of females. Horm Behav. 1986 Dec;20(4):474–482. doi: 10.1016/0018-506x(86)90009-7. [DOI] [PubMed] [Google Scholar]
  57. Ross P. M., Whysner J., Covello V. T., Kuschner M., Rifkind A. B., Sedler M. J., Trichopoulos D., Williams G. M. Olfaction and symptoms in the multiple chemical sensitivities syndrome. Prev Med. 1999 May;28(5):467–480. doi: 10.1006/pmed.1998.0469. [DOI] [PubMed] [Google Scholar]
  58. Shusterman D. Critical review: the health significance of environmental odor pollution. Arch Environ Health. 1992 Jan-Feb;47(1):76–87. doi: 10.1080/00039896.1992.9935948. [DOI] [PubMed] [Google Scholar]
  59. Siegel S., Kreutzer R. Pavlovian conditioning and multiple chemical sensitivity. Environ Health Perspect. 1997 Mar;105 (Suppl 2):521–526. doi: 10.1289/ehp.97105s2521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Siegel S. Multiple chemical sensitivity as a conditional response. Toxicol Ind Health. 1999 Apr-Jun;15(3-4):323–330. doi: 10.1177/074823379901500306. [DOI] [PubMed] [Google Scholar]
  61. Simon G. E., Daniell W., Stockbridge H., Claypoole K., Rosenstock L. Immunologic, psychological, and neuropsychological factors in multiple chemical sensitivity. A controlled study. Ann Intern Med. 1993 Jul 15;119(2):97–103. doi: 10.7326/0003-4819-119-2-199307150-00001. [DOI] [PubMed] [Google Scholar]
  62. Sobel N., Prabhakaran V., Hartley C. A., Desmond J. E., Glover G. H., Sullivan E. V., Gabrieli J. D. Blind smell: brain activation induced by an undetected air-borne chemical. Brain. 1999 Feb;122(Pt 2):209–217. doi: 10.1093/brain/122.2.209. [DOI] [PubMed] [Google Scholar]
  63. Sparks P. J., Daniell W., Black D. W., Kipen H. M., Altman L. C., Simon G. E., Terr A. I. Multiple chemical sensitivity syndrome: a clinical perspective. I. Case definition, theories of pathogenesis, and research needs. J Occup Med. 1994 Jul;36(7):718–730. [PubMed] [Google Scholar]
  64. Sparks P. J., Daniell W., Black D. W., Kipen H. M., Altman L. C., Simon G. E., Terr A. I. Multiple chemical sensitivity syndrome: a clinical perspective. II. Evaluation, diagnostic testing, treatment, and social considerations. J Occup Med. 1994 Jul;36(7):731–737. [PubMed] [Google Scholar]
  65. Stensaas L. J., Lavker R. M., Monti-Bloch L., Grosser B. I., Berliner D. L. Ultrastructure of the human vomeronasal organ. J Steroid Biochem Mol Biol. 1991 Oct;39(4B):553–560. doi: 10.1016/0960-0760(91)90252-z. [DOI] [PubMed] [Google Scholar]
  66. Stern K., McClintock M. K. Regulation of ovulation by human pheromones. Nature. 1998 Mar 12;392(6672):177–179. doi: 10.1038/32408. [DOI] [PubMed] [Google Scholar]
  67. Takami S., Getchell M. L., Chen Y., Monti-Bloch L., Berliner D. L., Stensaas L. J., Getchell T. V. Vomeronasal epithelial cells of the adult human express neuron-specific molecules. Neuroreport. 1993 Apr;4(4):375–378. doi: 10.1097/00001756-199304000-00008. [DOI] [PubMed] [Google Scholar]
  68. Trotier D., Eloit C., Wassef M., Talmain G., Bensimon J. L., Døving K. B., Ferrand J. The vomeronasal cavity in adult humans. Chem Senses. 2000 Aug;25(4):369–380. doi: 10.1093/chemse/25.4.369. [DOI] [PubMed] [Google Scholar]
  69. Van den Bergh O., Stegen K., Van Diest I., Raes C., Stulens P., Eelen P., Veulemans H., Van de Woestijne K. P., Nemery B. Acquisition and extinction of somatic symptoms in response to odours: a Pavlovian paradigm relevant to multiple chemical sensitivity. Occup Environ Med. 1999 May;56(5):295–301. doi: 10.1136/oem.56.5.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Weiss B. Neurobehavioral properties of chemical sensitivity syndromes. Neurotoxicology. 1998 Apr;19(2):259–268. [PubMed] [Google Scholar]
  71. White M. C., Johnson C. A., Ashley D. L., Buchta T. M., Pelletier D. J. Exposure to methyl tertiary-butyl ether from oxygenated gasoline in Stamford, Connecticut. Arch Environ Health. 1995 May-Jun;50(3):183–189. doi: 10.1080/00039896.1995.9940385. [DOI] [PubMed] [Google Scholar]
  72. Wysocki C. J. Neurobehavioral evidence for the involvement of the vomeronasal system in mammalian reproduction. Neurosci Biobehav Rev. 1979 Winter;3(4):301–341. doi: 10.1016/0149-7634(79)90015-0. [DOI] [PubMed] [Google Scholar]
  73. Zbar R. I., Zbar L. I., Dudley C., Trott S. A., Rohrich R. J., Moss R. L. A classification schema for the vomeronasal organ in humans. Plast Reconstr Surg. 2000 Apr;105(4):1284–1288. doi: 10.1097/00006534-200004040-00004. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES